Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 144 Records) |
Query Trace: Adenocarcinoma and Ros1[original query] |
---|
The Genomics of Colorectal Cancer in Populations with African and European Ancestry. Cancer discovery 2022 Feb . Myer Parvathi A, Lee Jessica K, Madison Russell W, Pradhan Kith, Newberg Justin Y, Isasi Carmen R, Klempner Samuel J, Frampton Garrett M, Ross Jeffrey S, Venstrom Jeffrey M, Schrock Alexa B, Das Sudipto, Augenlicht Leonard, Verma Amit, Greally John M, Raj Srilakshmi M, Goel Sanjay, Ali Siraj |
NF1-Mutant Cancer and Immune Checkpoint Inhibitors: A Large Database Analysis. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e421. Li X, Yu J, Wang |
The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung Cancer. JTO clinical and research reports 2021 Jul 2 (7): 100194. Gitlitz Barbara J, Novello Silvia, Vavalà Tiziana, Bittoni Marisa, Sable-Hunt Alicia, Pavlick Dean, Hsu Robert, Park S Lani, Chen Ruthia, Cooke Matthew, Moore Amy, Schrock Alexa B, Schiller Joan H, Addario Bonnie J, Oxnard Geoffrey |
Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases. Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
A retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
Relationship between clinical features and gene mutations in non-small cell lung cancer with osteoblastic bone metastasis. Cancer treatment and research communications 2021 Jul 28 100440. Takahara Yutaka, Nakase Keisuke, Nojiri Masafumi, Kato Ryo, Shinomiya Shohei, Oikawa Taku, Mizuno Shi |
Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces. Annals of translational medicine 2021 Jun 9 (12): 985. Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu |
Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors. Frontiers in pharmacology 2021 6 12 645862. Wen Yang, Lin Anqi, Zhu Weiliang, Wei Ting, Luo Peng, Guo Linlang, Zhang Ji |
Genetic Alteration Profiling of Chinese Lung Adenocarcinoma and Its Effect on Targeted Therapy Efficacy. Frontiers in oncology 2021 12 11 726547. Liu Jie, Xu Wang-Yang, Ye Maosong, Liu Zilong, Li Ch |
Programmed death-ligand 1 expression and its associations with clinicopathological features, prognosis, and driver oncogene alterations in surgically resected lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2021 Sep 161 163-170. Takamochi Kazuya, Hara Kieko, Hayashi Takuo, Kohsaka Shinji, Takahashi Fumiyuki, Suehara Yoshiyuki, Suzuki Ken |
Analysis of actionable genetic alterations in lung carcinoma from the VA National Precision Oncology Program. Seminars in oncology 2022 Jul . Jalal Shadia I, Guo Aixia, Ahmed Sara, Kelley Michael |
A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib. BMC medical genomics 2022 Jun 15 (1): 141. Chen Yan, Jiang Bo, He Yuange, Zhang Chu, Zhou Wenjie, Fang Cheng, Gu Dejian, Zhang Minxia, Ji Mei, Shi Juntao, Yang X |
Clinicopathological Impact of the Spread through Air Space in Non-Small Cell Lung Cancer: A Meta-Analysis. Diagnostics (Basel, Switzerland) 2022 Apr 12 (5): . Pyo Jung-Soo, Kim Nae |
Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma. Journal of Cancer 2022 4 13 (5): 1565-1572. Wu Xiaonan, Zhao Jun, Yang Ling, Nie Xin, Wang Zheng, Zhang Ping, Li Chao, Hu Xueqing, Tang Min, Yi Yuting, Du Xinhua, Xia Xuefeng, Guan Yanfang, Yu Zicheng, Gu Wenguang, Quan Xiangming, Li Lin, Shi Ho |
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations. European journal of cancer (Oxford, England : 1990) 2022 3 167 142-148. Riudavets Mariona, Auclin Edouard, Mosteiro Miguel, Dempsey Naomi, Majem Margarita, Lobefaro Riccardo, López-Castro Rafael, Bosch-Barrera Joaquim, Pilotto Sara, Escalera Elena, Tagliamento Marco, Mosquera Joaquin, Zalcman Gerard, Aboubakar-Nana Frank, Ponce Santiago, Dal Maso Alessandro, Spotti Martina, Mielgo-Rubio Xabier, Mussat Elodie, Reyes Roxana, Benítez José-Carlos, Lupinacci Lorena, Duchemann Boris, De Giglio Andrea, Blaquier Juan, Audigier-Valette Clarisse, Scheffler Matthias, Nadal Ernest, Lopes Gilberto, Signorelli Diego, Garcia-Campelo Rosario, Menis Jessica, Bluthgen Virginia, Campayo Marc, Recondo Gonzalo, Besse Benjamin, Planchard David, Mezquita Lau |
Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma. The oncologist 2022 3 27 (6): 476-486. Mack Philip C, Klein Michael I, Ayers Kristin L, Zhou Xiang, Guin Sunny, Fink Marc, Rossi Michael, Ai-Kateb Hussam, O'Connell Timmy, Hantash Feras M, Oh William K, Newman Scott, Schadt Eric E, Chen Rong, Hirsch Fred |
Analysis of real-word mutations of lung cancer driver genes in five regions of China. Translational cancer research 2022 2 8 (7): 2581-2592. Sun Mengyao, Guo Ye, Shao Guoguang, Duan Xiumei, Yang Zhiguang, Zhang Peng, Liu Yunpeng, Dong Yutong, Wang Xu, Xu Yinghui, Sun Chao, Ma Kew |
Correlative analysis of gene mutation and clinical features in patients with non-small cell lung cancer. Translational cancer research 2022 2 8 (3): 736-751. Kuang Xiao, Xiao Jian, Dai Long-Xia, Zhang Li-Hai, He Bi-X |
Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations. ESMO open 2022 Dec 7 (6): 100742. Wang H-Y, Wu S-G, Lin Y-T, Chen C-Y, Shih J |
Actionable mutations in non-small cell lung cancer in patients at hospital de Especialidades Eugenio Espejo, Ecuador 2017-2020. Drug metabolism and personalized therapy 2022 12 . Fernández Freire Miguel Ángel, Gálvez Salazar Gabriela Isabel, Scudeler Mariana Meira, Rodrigues-Soares Fernanda, Jaramillo Koupermann Gabriela Fernanda, Moreno Ocampo Andrea Pao |
Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions. The clinical respiratory journal 2022 Jan . Liu Qinghua, Huang Qingyan, Yu Zhikang, Wu Hemi |
Prevalence of targeted therapy-related genetic variations in NSCLC and their relationship with clinicopathological characteristics. PloS one 2022 17 (1): e0262822. Li Fanghua, Ye Peng, Cai Peiling, Dong Dandan, Zhang Yihao, Yang Yue, Sun Xingwa |
The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature 2023 4 616 (7957): 525-533. Frankell Alexander M, Dietzen Michelle, Al Bakir Maise, Lim Emilia L, Karasaki Takahiro, Ward Sophia, Veeriah Selvaraju, Colliver Emma, Huebner Ariana, Bunkum Abigail, Hill Mark S, Grigoriadis Kristiana, Moore David A, Black James R M, Liu Wing Kin, Thol Kerstin, Pich Oriol, Watkins Thomas B K, Naceur-Lombardelli Cristina, Cook Daniel E, Salgado Roberto, Wilson Gareth A, Bailey Chris, Angelova Mihaela, Bentham Robert, Martínez-Ruiz Carlos, Abbosh Christopher, Nicholson Andrew G, Le Quesne John, Biswas Dhruva, Rosenthal Rachel, Puttick Clare, Hessey Sonya, Lee Claudia, Prymas Paulina, Toncheva Antonia, Smith Jon, Xing Wei, Nicod Jerome, Price Gillian, Kerr Keith M, Naidu Babu, Middleton Gary, Blyth Kevin G, Fennell Dean A, Forster Martin D, Lee Siow Ming, Falzon Mary, Hewish Madeleine, Shackcloth Michael J, Lim Eric, Benafif Sarah, Russell Peter, Boleti Ekaterini, Krebs Matthew G, Lester Jason F, Papadatos-Pastos Dionysis, Ahmad Tanya, Thakrar Ricky M, Lawrence David, Navani Neal, Janes Sam M, Dive Caroline, Blackhall Fiona H, Summers Yvonne, Cave Judith, Marafioti Teresa, Herrero Javier, Quezada Sergio A, Peggs Karl S, Schwarz Roland F, Van Loo Peter, Miedema Daniël M, Birkbak Nicolai J, Hiley Crispin T, Hackshaw Allan, Zaccaria Simone, , Jamal-Hanjani Mariam, McGranahan Nicholas, Swanton Charl |
Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With ROS1-Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort Study. JCO precision oncology 2023 3 7 e2200614. Huang Zhe, Yan Huan, Zeng Liang, Xu Qinqin, Guo Wenhuan, Lin Shaoding, Jiang Wenjuan, Wang Zhan, Deng Li, Qin Haoyue, Zhang Xing, Tong Fan, Zhang Ruiguang, Liu Zhaoyi, Zhang Lin, Dong Xiaorong, Yang Nong, Zhang Yongcha |
Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data. Frontiers in immunology 2023 3 14 1090838. Li Mengyuan, Gao Xuejiao, Wang Xiaoshe |
Application of the Novel Grading System of Invasive Pulmonary Adenocarcinoma in a Real Diagnostic Scenario: A Brief Report of 9353 Cases. JTO clinical and research reports 2023 3 4 (3): 100465. She Yunlang, Zhong Yifan, Hou Likun, Zhao Shengnan, Zhang Liping, Xie Dong, Zhu Yuming, Wu Chunyan, Chen Cha |
[Application of the WHO Classification of Thoracic Tumors (2021) grading system in invasive pulmonary adenocarcinoma and its correlation with the targeted genes' variations]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2023 2 52 (2): 129-135. Hou L K, Zhang L P, Huang Y, Dong Z W, Xie H K, Zhang W, Wu W, Wu C |
ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing. Gynecologic oncology 2023 2 171 59-66. Machida Hiroko, Matsuo Koji, Tanaka Masayuki, Kitatani Kanae, Takase Akinori, Yokoyama Keiko, Kajiwara Hiroshi, Yasaka Miwa, Ikeda Masae, Yoshida Hiroshi, Hirasawa Takeshi, Mikami Mik |
An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncology. Laboratory investigation; a journal of technical methods and pathology 2023 2 101 (5): 648-660. Piton Nicolas, Lanic Marie-Delphine, Marguet Florent, Lamy Aude, Blanchard France, Guisier Florian, Viennot Mathieu, Salaün Mathieu, Thiberville Luc, Jardin Fabrice, Sabourin Jean-Christophe, Ruminy Philip |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: